MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 49 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 4.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,325 | +3.3% | 3,850 | 0.0% | 0.00% | – |
| Q2 2023 | $10,964 | +2675.7% | 3,850 | +3750.0% | 0.00% | – |
| Q1 2023 | $395 | -0.3% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $396 | -98.5% | 100 | -96.5% | 0.00% | – |
| Q3 2022 | $26,000 | -70.5% | 2,880 | -80.6% | 0.00% | – |
| Q2 2022 | $88,000 | -6.4% | 14,842 | 0.0% | 0.00% | – |
| Q1 2022 | $94,000 | -2.1% | 14,842 | +0.7% | 0.00% | – |
| Q4 2021 | $96,000 | – | 14,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |